Company Overview

Company name: Venom Extracts
Description: Developer and marketer of a range of cannabis extracts and related products to licensed retailers in Arizona. The company focusing on the development of a range of cannabis concentrates including curaleaf, kompo care, superior organics, urban greenhouse and alternative medicine, enabling it to offer unified product varieties to customers.
Year founded: 2017
Parent company: Hollister Biosciences
Industry: Healthcare | Group: | Code:
Website: www.venomextracts.com
Employees: 15
City: Phoenix
State: Arizona
Country: United States
Region:

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Exchange:
Ticker:
Revenue (USD Million): 12.35
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA): 1.87
Fiscal period: FY 2019
Financing Status: The company was acquired by Hollister Biosciences (CNQ: HOLL) for CAD 20 million on March 30, 2020. The all-stock purchase price is anticipated to be CDN$ 20,000,000, with 70% to be paid upfront and 30% to be paid upon milestone achievements related to revenue targets for Venom.
Number of active investors:
Profile last updated: 15-Apr-2020
Last known valuation:
Last known valuation date: 30-Mar-2020